MedPath

Terbinafine Hydrochloride

Terbinafine Hydrochloride Tablets

Approved
Approval ID

dfb8fc2d-4899-4891-a985-755fbdf1d525

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 9, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Terbinafine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-630
Application NumberANDA077533
Product Classification
M
Marketing Category
C73584
G
Generic Name
Terbinafine Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateJuly 12, 2010
FDA Product Classification

INGREDIENTS (6)

SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
TERBINAFINE HYDROCHLORIDEActive
Quantity: 250 mg in 1 1
Code: 012C11ZU6G
Classification: ACTIM
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Terbinafine Hydrochloride - FDA Drug Approval Details